NTRA Natera
- 95.550
- -0.110-0.11%
- 109.300
- +13.750+14.39%
Natera News
Natera (NTRA.US): The 2024 Q1 financial report achieved revenue of US$367.7 million, with a previous value of US$241.8 million, with an expected value of US$316.3 million; earnings per share were -0.56 dollars, the previous value was -1.23 dollars, and th
Natera (NTRA.US): The 2024 Q1 financial report achieved revenue of US$367.7 million, with a previous value of US$241.8 million, with an expected value of US$316.3 million; earnings per share were -0.56 dollars, the previous value was -1.23 dollars, and the expected value was -0.70 dollars.
Stocks to Watch: Funko, Natera, FIGS, Groupon
By Ben Glickman Funko named Cynthia Williams, former president of Hasbro's Wizards of the Coast and digital gaming unit, as its next chief executive effective later this month, ending a 10-month stre
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersSensus Healthcare (NASDAQ:SRTS) shares increased by 33.3% to $5.08 during Thursday's after-market session. The market value of their outstanding shares is at $83.2 million. As per the news, the
Natera Sees 2024 Total Revenue $1.42B-$1.45B Vs $1.34B Est.
Natera Sees 2024 Total Revenue $1.42B-$1.45B Vs $1.34B Est.
Natera Shares Are Trading Higher Following Strong Q1 Earnings.
Natera Shares Are Trading Higher Following Strong Q1 Earnings.
Natera Q1 2024 GAAP EPS $(0.56) Beats $(0.71) Estimate, Sales $367.700M Beat $316.306M Estimate
Natera (NASDAQ:NTRA) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of $(0.71) by 21.13 percent. The company reported quarterly sales of $367.700 million whi
Earnings Flash (NTRA) NATERA Reports Q1 Revenue $367.7M, Vs. Street Est of $315.3M
04:06 PM EDT, 05/09/2024 (MT Newswires) -- Earnings Flash (NTRA) NATERA Reports Q1 Revenue $367.7M, vs. Street Est of $315.3M
Press Release: Natera Reports First Quarter 2024 Financial Results
Natera Reports First Quarter 2024 Financial Results AUSTIN, Texas--(BUSINESS WIRE)--May 09, 2024-- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today reported i
Natera 1Q Loss/Shr 56c >NTRA
Natera 1Q Loss/Shr 56c >NTRA
How Is The Market Feeling About Natera?
Natera's (NYSE:NTRA) short percent of float has fallen 10.16% since its last report. The company recently reported that it has 5.76 million shares sold short, which is 4.95% of all regular shares that
Unusual Options Activity: KVUE, MDT and Others Attract Market Bets, KVUE V/OI Ratio Reaches 243.9
EST May 7th Morning Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.O
Craig-Hallum Keeps Their Buy Rating on Natera (NTRA)
Natera(NTRA.US) Officer Sells US$175.34K in Common Stock
$Natera(NTRA.US)$ Officer Brophy Michael Burkes sold 1,866 shares of common stock on May 1, 2024 at an average price of $93.9676 for a total value of $175.34K.Source: Announcement What is statement of
Natera Published Personalized And Tumor-informed Molecular Residual Disease Test, Signatera, To Detect Recurrence Early In Patients With Early-Stage Breast Cancer In JCO Precision Oncology
Expanded EBLIS study with up to 12 years of clinical follow-up across all subtypes of breast cancer
New Natera Publication Bolsters Evidence for Extended Surveillance With Signatera in Breast Cancer
Expanded EBLIS study with up to 12 years of clinical follow-up across all subtypes of breast cancer Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA and genetic testing, today announced a new publication
Insider Sale: CFO Michael Brophy Sells Shares of Natera Inc (NTRA)
Press Release: Natera to Report Its First Quarter 2024 Results on May 9
Natera to Report its First Quarter 2024 Results on May 9 AUSTIN, Texas--(BUSINESS WIRE)--May 01, 2024-- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today annou
Form 144 | Natera(NTRA.US) Officer Proposes to Sell 173.31K in Common Stocks
SEC FILLINGS DISCLOSED/ May 1, $Natera(NTRA.US)$ Officer MICHAEL BURKES BROPHY intends to sell 1,866 shares of its common stock on May 1, with a total market value of approximately $173.31K. MICHAEL
Natera Announced The Launch Of A New CfDNA-based Fetal RhD Test
Natera Announced The Launch Of A New CfDNA-based Fetal RhD Test
Natera Launches Fetal RhD NIPT Supporting Ob/Gyn Physicians and Patients During RhIg Shortage
Backed by large clinical validation study with over 650 RhD-negative patients with confirmed outcomes, resulting in 100% sensitivity and >99% specificityAUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (N
Analysis
Price Target
No Data
